Background. Epidemiological studies conducted in low-and high-income countries showed that infants exposed to maternal human immunodeficiency virus (HIV) have a high risk of severe infections. Immune alterations during fetal life have been proposed as a possible mechanism.
could play an important role. First, nucleoside reverse transcriptase inhibitors used for PMTCT have been proposed to reduce infants' immunity to pathogens through their hematological toxicity [3, 18] . Second, maternal HIV infection is associated with alterations of several immune parameters in HEU infants. The chronic immune activation that is typical of HIV infection is also observed in HEU infants, and can be assessed by measuring the expression of activation markers by peripheral blood-innate immune cells [3, 18, 19] . In addition, HEU newborns have lower concentrations of antibodies to pathogens and vaccine antigens, as a result of lower concentrations in the mother and of a reduction of transplacental transfer [3, 18, 20, 21] . Although immune alterations have been proposed to contribute to the susceptibility of HEU infants to infectious pathogens, no correlation with clinical outcomes has yet been established [3] .
We previously reported a retrospective study of the incidence of hospitalization for infection in HEU infants born in Belgium between 1985 and 2006 [14] . This prospective study was conducted to assess the relative risk of hospitalization for infection in HEU versus HU infants. Maternal and infant characteristics were analyzed to determine whether risk factors were specific or common to HEU and HU infants. Immune parameters were measured at birth in both mothers and newborns to identify correlates of susceptibility.
METHODS

Study Population
The study was conducted at the Hôpital Saint-Pierre, Brussels, a public hospital and HIV reference center taking care of a population of diverse socioeconomic and ethnic backgrounds. Between December 2010 and November 2013, HIV-infected and -uninfected pregnant women were recruited from the 32 nd week of gestation, following informed consent at the hospital antenatal clinic. PMTCT included the administration of ART in pregnant women, zidovudine prophylaxis in infants during 6 weeks, and avoidance of breastfeeding, following European guidelines [22] . The absence of HIV transmission was defined by at least 2 negative HIV DNA polymerase chain reactions during the first 3 months of life and by a negative serology after 12 months of age. HIV-uninfected pregnant women did not present chronic disorders, including autoimmune or inflammatory diseases, and did not receive immunosuppressive therapy before pregnancy. Children were examined at birth and at 1, 2, 3, 4, 6, 9, and 12 months by a clinical investigator (T. G. or C. A.). Data collected at each visit were entered in standardized case report forms. All children were vaccinated according to the Belgian immunization program (www.vaccine-schedule. ecdc.europa.eu). Anticipating an incidence of hospitalization for infection in HEU infants at 17% [14] , a sample size of 120 infants per group was required to detect a 2-fold increased risk as compared to HU infants, with a 90% power, using a test of proportions for independent samples. The study was approved by the hospital Ethics Committee.
Clinical Outcome
The primary clinical outcome was hospitalization for infection for more than 24 hours over the first year of life. The decision to hospitalize for infection was made following local clinical care guidelines by emergency unit clinicians who were not informed of the study objectives. Hospitalization criteria included a fever before the age of 3 months, an infection requiring parenteral antibiotic therapy, respiratory distress with poor feeding or hypoxemia, a first episode of febrile seizure, gastro-enteritis with dehydration, or suspicion of sepsis. Neonatal sepsis was defined as an infection occurring before the age of 28 days and requiring intravenous antibiotic therapy for at least 5 days. Adjudication of a discharge diagnosis was made on the basis of routine hospital tests by senior ward clinicians not involved in the study.
Immune Markers
Serum levels of vaccines (diphtheria toxoid, tetanus toxoid, pertussis toxin, Haemophilus influenza type B, and Pneumococcus polysaccharides) and pathogen-specific antibodies (varicella zoster virus [VZV] , cytomegalovirus [CMV]) were measured by multiplex immunoassays [23, 24] . Phenotypes of peripheral blood monocyte subsets were analyzed by flow cytometry, as described in the Supplementary Data. Respiratory syncytial virus (RSV)-neutralizing antibodies were measured using a microneutralization assay [25] . RSV antigen-specific IgG were analyzed by Western blot [25, 26] . Immune markers were measured at birth in both maternal and cord blood. In addition, infant RSV antibodies were measured at 6 months of age to define the rates of natural infections.
Statistical Analyses
A description of the methods used for statistical analyses of clinical and immunological data is provided in the Supplementary Data.
RESULTS
We recruited 130 HIV-infected and 120 HIV-uninfected mothers during pregnancy (Supplementary Figure 1) . HIV-infected mothers were significantly more often of Sub-Saharan African origin, were older, and were more likely to be multiparous than HIV-uninfected mothers; the two groups were similar for education, occupation, and income (Table 1) . We enrolled 132 HEU children, including 2 twin pairs and 5 pairs of siblings, and 123 HU children, including 3 twin pairs and 1 pair of siblings, at birth (Supplementary Figure 1) . HEU children had lower gestational ages and birth weights than HU children. While none of the HEU infants were breastfed, 95% of HU infants were breastfed, for a median duration of 6 months. ART was initiated Table 1a ). The hazard ratio of hospitalization for infection in HEU versus HU infants was 1.78 before adjustment and 2.33 after adjusting for birth weight, gestational age, maternal African origin, age, literacy, level of education, and primiparity (Table 2) Tables 1 and 2 ). RSV bronchiolitis was the cause of hospitalization in 10 HEU infants, but in only 1 HU infant. In contrast, the rate of RSV seroconversion at 6 months was similar in both groups (Supplementary Table 3 and Supplementary Figure 3) . Notably, the incidence of hospitalizations for other causes than infections during the study period was not significantly different in HEU and HU infants (Supplementary Table 1 ). Risk factors associated with hospitalizations for infection were analyzed separately in HEU and HU infants (Table 3 and  Supplementary Table 4 ). In HEU infants, the time of initiation of maternal ART was significantly associated with the rate of infant hospitalization for infection (adjusted hazard ratio 2.31, 95% confidence interval 1.03-5.15). Intra-partum administration of antibiotics was associated with an increased risk of hospitalization for infection in both HEU and HU infants. The risk of hospitalization for infection was not associated with gestational age in HEU or HU infants or with the duration of breastfeeding in HU infants (Table 3, Supplementary Table 4 , and Supplementary Figure 4) .
The characteristics of HIV-infected mothers who initiated ART before or during pregnancy are presented in Table 4 . Mothers who initiated ART during pregnancy were younger and more often primiparous than mothers who conceived on ART. ART regimens initiated before pregnancy were heterogeneous, whereas regimens initiated during pregnancy predominantly included protease inhibitors. However, administration of protease inhibitors during pregnancy was not significantly associated with clinical outcomes of HEU infants (data not shown). At delivery, mothers who initiated ART during pregnancy had similar viral control and higher CD4 counts, as compared to mothers who initiated ART before pregnancy (Table 4) .
The role of time of initiation of maternal ART in HEU infants led us to compare the risk of infection-related hospitalization of infants born to mothers who initiated ART before or during pregnancy as compared to HU infants ( Figure 1) . As compared to HU infants, the adjusted hazard ratio of HEU infants was 3.84 when mothers initiated ART during pregnancy and only 1.42 when ART was initiated before pregnancy (Table 2) . Notably, the risk of hospitalization for infection was higher in infants born to mothers who initiated ART during the last as compared to the first 2 trimesters of pregnancy, although this difference did not reach statistical significance (Supplementary Figure 5) . The robustness of our findings was validated using alternate modeling approaches on the entire dataset, combining HU and HEU infants (Supplementary Table 5 ).
Immune Activation in Newborns and Transfer of Maternal Antibodies
Next, we sought to identify potential immune correlates of susceptibility to infection-related hospitalization. Markers of immune activation and the transfer of maternal antibodies to a panel of vaccine and pathogen antigens were measured at birth (Supplementary Tables 6-9 ). Markers of immune activation included the levels of expression of CD40, CD86, and HLA-DR by peripheral blood monocyte subsets (classical, intermediate, and non-classical) in mothers and newborns. The 3 subsets of monocytes are considered to play distinct roles in immune and inflammatory responses by expressing distinct profiles of cytokines and homing receptors [27] .
First, we used t-distributed stochastic neighbor embedding (tSNE) to visualize how markers of immune activation and the transfer of maternal antibodies varied across the 3 groups. For each subject, tSNE reduces the entire set of measured immune parameters to 2 values that best summarize the subject's immunological profile [28] . This summarization, formally known as dimensionality reduction, is unsupervised: that is, the method does not use any information regarding which clinical group (HU, HEU infants born to mothers who initiated ART before pregnancy, or HEU infants born to mothers who initiated ART during pregnancy) each subject belongs to. This analysis indicated that immune parameters were very different, not only between HU and HEU mother-newborn pairs, but also according to the time of initiation of maternal ART during pregnancy ( Figure 2 ). These separations involved both a reduced transfer of maternal antibodies and a significantly higher level of monocyte activation (Figure 2 ). The lowest maternal antibody transfer ratios were observed in HEU newborns of mothers who The hazard ratio was adjusted for gestational age, birth weight, illiteracy, upper level of education, African origin, primiparity, and maternal age at birth. P values were determined using the Wald test.
Abbreviations: ART, antiretroviral therapy; aHR, adjusted hazard ratio; cHR, crude hazard ratio; CI, confidence interval; HEU, human immunodeficiency virus-exposed, uninfected; HU, human immunodeficiency virus-unexposed.
initiated ART during pregnancy ( Figure 2 and Supplementary  Table 8 ). HIV-infected mothers who initiated ART during pregnancy and their newborns also displayed the highest levels of monocyte activation (Figure 2 and Supplementary Table 9 ).
Immune Parameters and Risk of Hospitalization for Infection
To obtain a more refined understanding of the immune correlates of risk, we focused on the potential link between immune alterations and clinical outcomes in the highest-risk group. We used a multivariate least absolute shrinkage and selection operator/partial least squares (least absolute shrinkage and selection operator/partial least squares (LASSO/PLS)) model to separate HEU infants born to mothers who initiated ART during pregnancy, based on whether the infants were hospitalized during the first year of life. The model identifies only a minimal set of markers that are most relevant in terms of predicting clinical outcomes [29] . Based on mathematical combinations of these minimal immune markers, or composite latent variables, the model then classifies infants into 2 groups: hospitalized or not ( Figure 3) . We assessed the robustness of the model in a rigorous 5-fold cross-validation framework. The model achieved high overall median classification accuracy and had balanced performance for both groups (Figure 3) . The model included 3 immune parameters: an increased risk of hospitalization was associated with (1) higher titers of maternal antibodies against VZV, (2) the higher expression of CD40 by non-classical newborn monocytes, and (3) lower transfer ratios of maternal antibodies to Pneumococcus 18s polysaccharides (Figure 3 ). While the 3 immune parameters included in the model have the best predictive power, there could be other correlated parameters that capture some information relevant to the risk of hospitalization. To obtain a holistic understanding of all immune parameters tracking with hospitalization risks, we explored other features significantly correlated with the 3 minimal markers. Maternal VZV antibody levels were correlated with newborn VZV antibody levels ( Figure 3 ). The expression of activation markers by newborn and maternal monocyte subsets and maternal antibody transfer ratios followed complex coordinations, suggesting the involvement of multiple pathways in the risk of infection-related hospitalization in HEU infants (Figure 3 ).
DISCUSSION
In this prospective birth-cohort study, HEU infants born in Belgium had a 2-fold increased risk of hospitalization for infection as compared to HU infants. This result agrees with the range of hospitalization risks reported from Mozambique and South Africa [9] [10] [11] . In agreement with previous studies, most infection-related hospitalizations occurred during the first months of life and involved diverse bacterial and viral pathogens [3, 5, 7, [12] [13] [14] [15] [16] .
This study provides 2 novel and important insights. First, in our study population, most of the excess risk of infection-related hospitalization in HEU as compared to HU infants could be attributed to the initiation of ART during rather than before pregnancy. This observation supports the notion that the activity level of maternal HIV infection is a central determinant of the risk of severe infections in HEU infants [6, 7, 13, 17] . It also indicates that the increased burden of infectious diseases observed in HEU infants can be reduced by the control of HIV replication throughout pregnancy.
The second novel insight of our study is that the risk of hospitalization for infection in HEU infants was correlated with immune ). Follow-up was censored at the time of the first hospitalization for infection, at the time of loss to follow-up, or at 12 months of age. Numbers are infants at risk at each time point. HEU ART before refers to HIV-exposed, uninfected infants born to mothers who initiated ART before pregnancy; HEU ART during refers to HIV-exposed, uninfected infants born to mothers who initiated ART during pregnancy. Abbreviations: aHR, adjusted hazard ratio; ART, antiretroviral therapy; CI, confidence interval; HIV, human immunodeficiency virus; HEU, HIV-exposed, uninfected; HU, HIV-unexposed. Hazard ratios were adjusted for gestational age and maternal age at birth, unless otherwise noted. P values were determined using the Wald test.
Abbreviations: aHR, adjusted hazard ratio; ART, antiretroviral therapy; cHR, crude hazard ratio (95% confidence limits); CI, confidence interval; HEU, human immunodeficiency virus-exposed, uninfected; VL, viral load. a Hazard ratio adjusted for gestational age. alterations measured at birth. The activation of monocytes and the reduced transfer of maternal antibodies were observed in HEU newborns, confirming previous studies [3, [18] [19] [20] [21] . This study showed that the most intense immune alterations are detected in the highest-risk group: HEU infants born to mothers who initiated ART during pregnancy. Modeling demonstrated that, within this group, immune alterations predicted clinical outcomes. This observation has important implications for the management of this vulnerable population. Identifying HEU newborns at risk of severe infections using immune biomarkers could guide the implementation of preventive interventions, including anti-microbial prophylaxis and immunization. Our observation that HEU infants had an increased risk of hospitalization following an RSV infection, with similar seroconversion rates, supports the notion that this population is at an increased risk of severe infections rather than simply infections per se [14, 15, [30] [31] [32] . Understanding the mechanisms involved could help in the design of interventions targeting the immune system [33] . Modeling indicated that several immune pathways are likely to be involved. The reduced transfer of maternal antibodies to multiple pathogens is likely to contribute, and may be overcome by immunization during pregnancy [34] . On the other hand, immune activation involving innate immune cells may promote pathogenic inflammatory responses [3, 18] . Indeed, studies suggest that severe infections in early life may be related to excessive inflammation, rather than to an immaturity of the immune system, and that interventions promoting immune homeostasis may reduce the burden of severe infections in infants [35] . The association between the risk of hospitalization for infections with the level of maternal anti-VZV antibodies is intriguing. The history of zoster infection was Figure 2 . Immune parameters measured at birth in HIV-exposed and unexposed newborns and their mothers. (A) Stratification according to immune parameters (maternal antibody transfer ratios and expression of markers of activation by peripheral blood monocyte subsets) measured at birth in newborns and mothers using t-SNE. (B) Median maternal antibody transfer ratios to pathogen and vaccine antigens. Antibody data were available for 71% of mothers and newborns. (C-E) Violin plots illustrating CD40 expression by maternal and newborn peripheral blood monocyte subsets. Monocyte phenotype data were available from 45% of mothers and 41% of newborns. The + sign indicates the mean and the ☐ indicates the median MFI. *P < .01 by the Mann-Whitney U test. HEU ART before refers to HIV-exposed, uninfected infants born to mothers who initiated ART before pregnancy; HEU ART during refers to HIV-exposed, uninfected infants born to mothers who initiated ART during pregnancy. Abbreviations: ART, antiretroviral therapy; DTX, diphtheria toxoid; Hib, Haemophilus influenza type B; HEU, HIV-exposed, uninfected; HIV, human immunodeficiency virus; HU, HIV-unexposed; MFI, mean fluorescence intensities; PP, Pneumococcus polysaccharide; PTX, pertussis toxin; RSV, respiratory syncytial virus; t-SNE, t-distributed stochastic neighbor embedding; TTX, tetanus toxoid; VZV, varicella zoster virus.
not available for most patients. The absence of an association with anti-CMV antibodies does not support a role for the reactivation of persistent viruses that would result from immune activation.
Several characteristics of the study may limit its interpretation and its implications. The study was conducted at a single site in Belgium. This increased the homogeneity of the study population and the consistency of the study procedures, but may limit the generalizability of the results. As the decision of hospitalization was made independently of the HIV status of the mother, this information is unlikely to have biased the results. The sample size was not sufficient to analyze the severity of infections or the impact of ART regimens and durations during pregnancy. The cohorts of HIV-infected and HIV-uninfected mothers and their children differed for several parameters. However, adjusting our analysis for most of these parameters did not affect the results. Gestational age was lower in HEU than in HU newborns, and prematurity is a known risk factor for infectious diseases [36] . However, gestational age was not significantly associated with the risk of hospitalization for infection in our study population, and the increased risk of HEU infants was still observed after the exclusion of prematurely-born infants. As HEU infants were not breastfed, the analysis could not be adjusted for this (B) Antibody data were available for 53% of mothers and newborns. Monocyte phenotype data were available from 53% of mothers and 43% of newborns. The violin plots illustrate classification accuracy (overall, as well as for each of the 2 groups) of the LASSO/PLS model, as measured in a 5-fold cross-validation framework, across 50 independent runs. The symbol + indicates the mean and ☐ indicates the median classification accuracy. (C) VIP scores for parameters used by the model. The length of the bars corresponds to the magnitude of VIP scores, while direction is based on a positive or negative association with risk (i.e., increased risk of hospitalization). (D) Networks illustrating co-correlates of the parameters used in the model. A relationship is defined as significant if the Spearman correlation coefficient is >0.5 and the P value associated with the correlation coefficient, post-Bonferroni multiple-testing correction, is <0.05. Abbreviations: ART, antiretroviral therapy; c-monocytes, classical monocytes; DTX, diphtheria toxoid; HEU, human immunodeficiency virus-exposed, uninfected; i-monocytes, intermediate monocytes; LASSO/PLS, least absolute shrinkage and selection operator/partial least squares; LV, latent variable; nc-monocytes, non-classical monocytes; PP, Pneumococcus polysaccharide; PTX, pertussis toxin; TR, transfer ratio; TTX, tetanus toxoid; VIP, variable importance in the projection; VZV, varicella zoster virus.
parameter. However, the risk of infection-related hospitalization was similar in HEU infants born to mothers who initiated ART before pregnancy (who were not breastfed) and in HU infants (who were almost all breastfed). In addition, the duration of breastfeeding was not significantly associated with the risk of hospitalization for infection in HU infants. The limited impact of breastfeeding on the risk of hospitalization for infection in our study population may not be unexpected. Indeed, while there is strong supportive evidence for a protective effect of breastfeeding on infectious morbidity in LMIC, the evidence from HIC is less consistent [37] [38] [39] . Studies should be conducted in LMIC to determine the impact of pre-conception ART and breastfeeding on the risk of severe infections in HEU infants.
In conclusion, the initiation of maternal ART before pregnancy is associated with a reduced risk of hospitalization for infection in HEU infants born in a HIC, and this effect could be related to the prevention of immune alterations during fetal life. The lifelong administration of ART to all HIV-infected women, as recommended by the World Health Organization [40] , could therefore positively impact the health of HIV-exposed infants beyond PMTCT. Confirming these observations in LMIC, where the burden of HIV and pediatric infectious diseases are highest, would have critical implications for the health of HEU infants worldwide.
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